Results 271 to 280 of about 181,215 (307)
Some of the next articles are maybe not open access.
Reperfusion Therapies in Acute Ischemic Stroke
Recent Patents on CNS Drug Discovery, 2015Acute Ischemic stroke (IS) remains a leading cause of mortality and long-term disability. Owing to the time-constraints, only a fraction of acute IS patients receive the established and approved thrombolytic therapy and a sizeable proportion of acute IS stroke survivors remain permanently disabled.
Leonard L L, Yeo +4 more
openaire +2 more sources
Revascularization and reperfusion therapy
2008This chapter focuses on revascularization and reperfusion therapy in the setting of ACS. Revascularization therapy is distinct from reperfusion therapy. The former takes place in non-ST-elevation or ST-elevation ACS, while reperfusion is employed only for ST-elevation myocardial infarction.
Anthony A Bavry, Deepak L Bhatt
openaire +1 more source
Reperfusion Therapy for Acute Vertebrobasilar Occlusion
Interventional Neuroradiology, 1997We reviewed retrospectively our experience in treating 10 patients with acute vertebrobasilar occlusion. Nine patients were treated with interventional reperfusion therapy and the remaining one patient with top of the basilar embolism was treated conservatively because of deep coma and decerebrate rigidity with severely reduced cerebral blood flow ...
H, Ohta +7 more
openaire +2 more sources
Therapy for early reperfusion after stroke
Nature Clinical Practice Cardiovascular Medicine, 2006Ischemic stroke is a leading cause of death and disability in the Western world. At present, intravenous administration of tissue plasminogen activator within 3 h of symptom onset is the only proven effective treatment to re-establish cerebral blood flow in the case of acute vessel occlusion.
Eric, Juttler +2 more
openaire +2 more sources
REPERFUSION THERAPY FOR ACUTE MYOCARDIAL INFARCTION
Emergency Medicine Clinics of North America, 2001A mechanical approach to reperfusion using direct coronary angioplasty is now an established and effective treatment for acute myocardial infarction, but it is not immediately available at most community hospitals. This article will outline the indications for use of reperfusion therapy on patients with AMI, discuss all currently available treatment ...
J A, McPherson, R S, Gibson
openaire +2 more sources
THERAPY OF REPERFUSION ARRHYTMIAS
Bratislavské lekárske listy, 2004INTRODUCTION: According to literature, reperfusion arrhytmias that cause hemodynamic instability or subjective discomfort in acute myocardial infarction (AMI) should be treated METHODS AND PATIENTS: Authors investigated the frequency of different types of therapy used in reperfusion arrhytmias (frequent premature ventricular complexes, non-sustained ...
Tomulić, Vjekoslav +4 more
openaire +2 more sources
Reperfusion Therapy in Acute Myocardial Infarction
New England Journal of Medicine, 2002Coronary arterial occlusion due to thrombosis is the cause of most cases of myocardial infarction accompanied by ST-segment elevation.
Richard A, Lange, L David, Hillis
openaire +2 more sources
Current gaps in acute reperfusion therapies
Current Opinion in NeurologyPurpose of review Advances in intravenous thrombolysis and endovascular thrombectomy have significantly reduced disability and improved outcomes associated with acute ischemic stroke. Recent findings An expansion of indications for reperfusion therapies in select groups of patients ...
Thanh N, Nguyen +4 more
openaire +2 more sources
Reperfusion: Pathophysiologie, Prävention, Therapie
1991Es ist eine Binsenweiheit, das ohne Reperfusion die Wiederherstellung einer gestorten oder transplantierten Organfunktion nicht moglich ist. Es gibt sogar Untersuchungen, wonach die langfristige Restitution eines zerebralen Insultes um so besser ausfallt, je rigoroser initial reperfundiert wurde [9].
openaire +1 more source
Adjunctive Reperfusion Therapy Post-AMI
2011• Reperfusion of the occluded coronary artery in an ST-segment-elevation myocardial infarction is the most effective approach for reducing infarct size, preserving left ventricular ejection fraction, lowering the incidence and severity of congestive heart failure and improving prognosis• Hence, several pharmacologic agents intended to improve target ...
Thorsten Reffelmann, Robert Kloner
openaire +1 more source

